Recall Register

Food, drugs, devices › Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)

Device recall: Medtronic CareLink 2090 Programmer. Used to interrogate and program Medtronic and Vitatron implantable devices, such as

FDA enforcement event 84944 · Class II · initiated 30 Jan 2020 · status Ongoing

DeviceVoluntary: Firm initiated2 product recordsMounds View, MN

Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) (Mounds View, MN) initiated this device recall on 30 Jan 2020; FDA lists 2 product records under event 84944, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 93% of the 916 device enforcement events initiated in 2020 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF) has 30 enforcement events on this register, with a median of 2 product records per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF), Mounds View, MN.

Reason for recall

"Medtronic Conexus Telemetry has been determined to contain two primary cyber vulnerabilities: improper access control and the cleartext transmission of sensitive information."

Distribution

"Worldwide distribution. US Nationwide including Puerto Rico, Argentina, Brazil, Colombia, Trinidad and Tobago, Venezuela, Dominican Republic, Bahamas, Peru, Bermuda, Barbados, Ecuador, Cayman…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-1524-2020Medtronic CareLink 2090 Programmer. Used to interrogate and program Medtronic and Vitatron implantable devices, such as pacemaker/ICD/CRT.23,180 devicesClass IIOngoing25 Mar 2020
Z-1525-2020Medtronic CareLink Encore 29901 Programmer. Used to interrogate and program Medtronic and Vitatron implantable devices, such as pacemaker/ICD/CRT.5,540 devicesClass IIOngoing25 Mar 2020

Context

93%of 2020 device events are Class II916 events that year
2product records in this eventfirm median: 2
30events on this register for the firm

Other enforcement events for Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)

InitiatedProduct (first record)TypeClassRecords
10 May 2023ICD-DR DDBB1D1 EVERA XT IS1/DF1 US, Model Number DDBB1D1; Implantable Cardioverter DefibrillatorsDeviceClass I120
22 Jun 2022Cobalt Implantable Cardioverter Defibrillators: a. Cobalt XT VR ICD, Model Numbers: DVPA2D1, DVPA2D4; b. Cobalt XT DR ICDeviceClass I6
20 Apr 2022The C304-HIS device features a guide wire to access the vein, a valve to reduce blood loss during the implant procedure,DeviceClass II1
12 Apr 2022Cobalt Models loaded with CareLink SmartSync Device Manager application software D00U005: a) Cobalt XT VR: DVPA2D1, DVPADeviceClass II2
18 Jan 2022LINQ II Insertable Cardiac MonitorDeviceClass II1
19 Nov 2021Instructions for Use for all model numbers of the Medtronic Abre Venous Self-Expanding Stent System.DeviceClass II1
8 Nov 2021Medical Device Identification Cards associated with Sprint Quattro Lead, Product/CFN 6935M72DeviceClass II2
12 Oct 2021Medtronic CareLink SmartSync Device Manager application software (D00U005) used by the following Medtronic Cobalt and CrDeviceClass II1
9 Sep 2021C315-HIS Delivery CatheterDeviceClass II1
1 Jun 2021Medtronic Reveal LINQ LNQ11 / PA96000DeviceClass II1

All 30 events for Medtronic Inc., Cardiac Rhythm and Heart Failure (CRHF)

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Medtronic Conexus Telemetry has been determined to contain two primary cyber vulnerabilities: improper access control and the cleartext transmission of sensitive information."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide distribution. US Nationwide including Puerto Rico, Argentina, Brazil, Colombia, Trinidad and Tobago, Venezuela, Dominican Republic, Bahamas, Peru, Bermuda, Barbados, Ecuador, Cayman…"

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.